Leonard P. Freedman, PhD
Dr. Freedman is the founding President of the Global Biological Standards Institute (GBSI). He has held leadership positions in basic biomedical research, drug discovery, and science policy in both the private sector and academia. Dr. Freedman is a recognized leader in the field of nuclear hormone receptors.
Before joining GBSI, Dr. Freedman served as Vice Dean for Research and Professor of Biochemistry and Molecular Biology at Jefferson Medical College, Thomas Jefferson University. Prior to his leadership role at Jefferson, Dr. Freedman led discovery research efforts in the pharmaceutical industry as a Vice President at Wyeth and Executive Director at Merck. Before moving to industry, Dr. Freedman was a Member and Professor of Cell Biology & Genetics at Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College.
Dr. Freedman has received several research awards, including the Boyer Research Award for Biomedical Research, and a MERIT award from the NIH. He was also the 2002 recipient of the Ernst Oppenheimer Award from The Endocrine Society. Dr. Freedman has published extensively and served on numerous scientific review panels and editorial boards. He was an editor of Molecular and Cellular Biology for ten years. In addition, Dr. Freedman has served on the Board of Directors of the American Type Culture Collection (ATCC).
Dr. Freedman earned a B.A. degree in Biology from Kalamazoo College, and a Ph.D. in Molecular Genetics from the University of Rochester. He completed his post-doctoral fellowship in the laboratory of Dr. Keith Yamamoto at the University of California, San Francisco.
About Global Biological Standards Institute (GBSI)
GBSI, a non-profit organization, is dedicated to enhancing the quality of biomedical research by advocating best practices and standards to accelerate the translation of research breakthroughs into life-saving therapies. For more information, visit GBSI.org; Twitter @GBSIorg.